Experimental & Molecular Medicine (EMM) is Korea's first biochemistry journal (founded in 1964) and is relaunched in 1996 as an Open Access, fully peer-reviewed international journal. It is a medical research journal devoted to publishing the latest developments in translational research and the recent discoveries in the biomedical field. Submission is encouraged of papers that involve genetic, molecular and cellular studies of human physiology and diseases. The journal seeks to highlight the improved clinical benefits for human health from experimental and translational research performed using specific molecular tools. Studies that encompass basic discoveries with clinical relevance as well as articles dealing with clear in vivo relevance and novelty will also be welcomed. Experimental & Molecular Medicine is an open access, online-only journal.
Topics of particular interest within the journal's scope include, but are not limited to, those listed below:
Cancer biology
Immunology
Neuroscience
Cardiovascular biology
Genetics and genomics
Gene therapy
Metabolic diseases
Stem cells and regenerative medicine
Physiology and diseases
Molecular Medicine.
《Experimental And Molecular Medicine》是一本由SPRINGERNATURE出版商出版的专业医学期刊,该刊创刊于1999年,刊期Quarterly,该刊已被国际权威数据库SCI、SCIE收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:生化与分子生物学 2区;医学:研究与实验 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖生化与分子生物学等领域,旨在及时、准确、全面地报道国内外生化与分子生物学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为12.153,平均审稿速度平均3月。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 2区 2区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | MEDICINE, RESEARCH & EXPERIMENTAL | Q1 | 12.153 |
BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
12.153 | 68 | 100.00% | 63.58% | 开放 | 平均3月 |